Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7241 results

Sort By:

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Study ID: NCT02074839
Start Date: 2014-03-01
End Date: 2026-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

291

Intervention / Treatment

AG-120

Sponsor

Institute of International Research Servier

Source: clinicaltrials.gov

Share:
Add to list

Study of REM-422 in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Study ID: NCT06118086
Start Date: 2023-12-20
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

65

Intervention / Treatment

REM-422

Sponsor

Remix Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Study ID: NCT06929286
Start Date: 2025-04-11
End Date: 2028-04
Study Type

Interventional

Study Phase

Phase3

No. of Participants

125

Intervention / Treatment

Nadophagen Firadenovec

Gemcitabine

Docetaxel

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1 Clinical Study of NXP900 in Subjects with Advanced Cancers

Study ID: NCT05873686
Start Date: 2023-10-26
End Date: 2025-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

NXP900

Sponsor

Nuqectis Pharma, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations

Study ID: NCT04409639
Start Date: 2021-01-12
End Date: 2026-08-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

29

Intervention / Treatment

Cobiet

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list

A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

Study ID: NCT06788639
Start Date: 2025-02-04
End Date: 2044-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Lisocabtagene maraleucel

Sponsor

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Source: clinicaltrials.gov

Share:
Add to list

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Study ID: NCT05896839
Start Date: 2024-07-24
End Date: 2027-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

16

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Ipilimumab

Kidney Biopsy

Magnetic Resonance Imaging

Nivolumab

Prednisone

Sirolimus

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients

Study ID: NCT06262139
Start Date: 2024-07-25
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

MT218 injection

Sponsor

song 吉吉

Source: clinicaltrials.gov

Share:
Add to list

Molecular and Immunohistochemical Profiling of Tumors in Patients with Parathyroid Tumors

Study ID: NCT03039439
Start Date: 2015-11-24
End Date: 2028-11-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

310

Intervention / Treatment

Biospecimen Collection

Laboratory Biomarker Analysis

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Study ID: NCT05961839
Start Date: 2023-09-27
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

50

Intervention / Treatment

SGR-2921

Sponsor

Schrödinger, Inc.

Source: clinicaltrials.gov

Share:
Add to list